en · de · es · pt
epitalon-notes.peptides3081.com › Info › Epitalon Background And Identification — Questions and Answers

Epitalon Background And Identification — Questions and Answers

By Editorial Desk · published 2026-01-28 · last reviewed 2026-02-15 · Info

Epithalamin raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

This page was last updated on 2026-02-15 and is reviewed periodically as new material appears.

Epitalon Background And Identification

Literature searches for this compound must account for several spelling variants. Indexing databases contain epitalon, epithalon, epithalone, and AEDG, and relevant records are scattered across Russian-language and English-language journals that do not consistently cross-cite. Early publications describe the parent extract as a mixture of many peptides, whereas later work addresses the single synthetic tetrapeptide. That shift in nomenclature complicates comparison between studies, because extract data and tetrapeptide data are sometimes cited interchangeably. A search strategy omitting the alternate spellings will return an incomplete set of references.

Reported biological findings come mainly from cell culture and rodent experiments. Those studies describe changes in telomerase catalytic subunit expression, melatonin rhythm amplitude, and antioxidant enzyme activity after peptide exposure. Human data are sparse and consist of small trials with limited blinding and inconsistent endpoints. The proposed mechanisms remain hypotheses rather than established facts, and there is no consensus on whether effects observed in animals carry over to people. Independent replication outside the original research groups is limited, which is a recognised gap in the published literature.

Epitalon Background and Nomenclature

The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.

Laboratory work has examined effects on telomerase activity in cultured cells, on melatonin rhythms in animals, and on markers of oxidative stress. Some experiments report measurable changes while others show none, and the reported findings rest largely on small studies. The absence of large independent trials means the generality of these results is unresolved rather than settled. Review articles occasionally apply the label geroprotector, a term that reflects a research hypothesis about ageing rather than an established clinical finding.

Epitalon at a glance

PropertyValueNotes
Chemical classSynthetic tetrapeptideFour amino acid residues
Residue sequenceAla-Glu-Asp-GlyAbbreviated AEDG
Approximate mass390.35 DaMonoisotopic, free base form
Parent preparationEpithalamin extractDerived from pineal tissue
Common spelling variantsEpithalon, epithalone, AEDGAffects literature retrieval

Peptide Identity and Research Origin

The published literature is dominated by a small number of research groups, much of it in Russian-language journals, and independent replication outside those groups is limited. Studies are typically small, use cultured cells or rodent models, and report endpoints that differ between papers, which makes comparison difficult. Large randomised human trials have not appeared in the indexed literature. Questions about absorption, distribution and clearance are therefore still treated as open in reviews that mention the compound.

Epitalon is a synthetic tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. Its design traces to epithalamin, a peptide fraction prepared from bovine pineal gland extracts that researchers in Saint Petersburg began investigating in the 1970s. The compound has a molecular formula of C14H22N4O9 and a nominal molecular mass near 390 daltons. It holds no approved drug status in the United States or the European Union, and material sold under this name is generally offered as a research chemical rather than a finished pharmaceutical product.

Proposed mechanisms centre on cell-culture observations rather than a defined receptor interaction. Several reports describe increased expression of the telomerase catalytic subunit after exposure of cultured human cells, and the authors attributed the effect to short peptide fragments entering the nucleus and influencing gene transcription. No receptor for the tetrapeptide has been identified, and the free peptide is expected to be degraded rapidly by plasma peptidases. Whether any measurable fraction reaches intact tissues after administration remains an unresolved question rather than an established finding.

Related pages on this site

Background and Proposed Mechanism

Published evidence comes mainly from Russian-language journals and from a single research group, with small sample sizes and limited independent replication. A few laboratories outside that group have examined related peptides and reported weaker or absent telomerase effects, so the central claim is best described as contested rather than settled. Rodent studies report modest changes in some ageing markers and in survival, but designs vary and control conditions are often sparse. No large randomised trial in humans has been published, and long-term safety data in healthy populations are correspondingly thin.

Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. It was designed at the St. Petersburg Institute of Bioregulation and Gerontology as a short, chemically defined analogue of epithalamin, a fraction obtained from bovine pineal tissue. Small peptide bioregulators of this type formed a long-running line of work there from the 1980s onward. Because the molecule is produced by solid-phase synthesis rather than extraction, its composition is exact and its purity can be measured directly.

Further detail

He attributed beriberi to the high levels of starch in rice being toxic. He believed that the toxicity was countered in a compound present in the rice polishings. An associate, Gerrit Grijns, correctly interpreted the connection between excessive consumption of polished rice and beriberi in 1901: He concluded that rice contains an essential nutrient in the outer layers of the grain that is removed by polishing. Eijkman was eventually awarded the Nobel Prize in Physiology and Medicine in 1929, because his observations led to the discovery of vitamins. In 1910, a Japanese agricultural chemist of Tokyo Imperial University, Umetaro Suzuki, isolated a water-soluble thiamine compound from rice bran, which he named aberic acid. (He later renamed it Orizanin.) He described the compound as not only an anti-beriberi factor, but also as being essential to human nutrition; however, this finding failed to gain publicity outside of Japan, because a claim that the compound was a new finding was omitted in translation of his publication from Japanese to German. In 1911 a Polish biochemist Casimir Funk isolated the antineuritic substance from rice bran (the modern thiamine) that he called a "vitamine" (on account of its containing an amino group). However, Funk did not completely characterize its chemical structure. Dutch chemists, Barend Coenraad Petrus Jansen and his closest collaborator Willem Frederik Donath, went on to isolate and crystallize the active agent in 1926, whose structure was determined by Robert Runnels Williams, in 1934.

The caffeine content of instant coffee is generally less than that of brewed coffee. One study comparing various home-prepared samples came to the result that regular instant coffee (not decaffeinated) has a median caffeine content of 66 mg per cup (range 29–117 mg per cup), with a median cup size of 225 ml (range 170–285 mL) and a caffeine concentration of 328 μg/mL (range 102–559 μg/mL). In comparison, drip or filter coffee was estimated to have a median caffeine content of 112 mg, with a median concentration of 621 μg/mL for the same cup size. Regarding antioxidants, the polyphenol content of a 180 ml cup of instant coffee has been estimated to be approximately 320 mg, compared to approximately 400 mg in a cup of brewed coffee of the same size.

Among prokaryotes, five major groups of bacteria have evolved the ability to photosynthesize, including heliobacteria, green sulfur and nonsulfur bacteria and proteobacteria. However, the only lineage where oxygenic photosynthesis has evolved is in the cyanobacteria, often known as blue-green algae for their blue-green (cyan) coloration. They are classified as the phylum Cyanobacteriota or Cyanophyta. However, this phylum also includes two classes of non-photosynthetic bacteria: Melainabacteria (also called Vampirovibrionia or Vampirovibrionophyceae) and Sericytochromatia (also known as Blackallbacteria). A third class contains the photosynthetic ones, known as Cyanophyceae (also called Cyanobacteriia or Oxyphotobacteria). As bacteria, their cells lack membrane-bound organelles, with the exception of thylakoids. Like other algae, cyanobacteria have chlorophyll a as their primary photosynthetic pigment. Their accessory pigments include phycobilins (phycoerythrobilin and phycocyanobilin), carotenoids and, in some cases, b, d, or f chlorophylls, generally distributed in phycobilisomes found in the surface of thylakoids. They display a variety of body forms, such as single cells, colonies, and unbranched or branched filaments. Their cells are commonly covered in a sheath of mucilage, and they also have a typical gram-negative bacterial cell wall composed largely of peptidoglycan. They have various storage particles, including cyanophycin as aminoacid and nitrogen reserves, "cyanophycean starch" (similar to plant amylose) for carbohydrates, and lipid droplets.

Human chorionic gonadotropin injection is extensively used for final maturation induction in lieu of luteinizing hormone. In the presence of one or more mature ovarian follicles, ovulation can be triggered by the administration of HCG. As ovulation will happen between 38 and 40 hours after a single HCG injection, procedures can be scheduled to take advantage of this time sequence, such as intrauterine insemination or sexual intercourse. Also, patients that undergo IVF, in general, receive HCG to trigger the ovulation process, but have an oocyte retrieval performed at about 34 to 36 hours after injection, a few hours before the eggs actually would be released from the ovary. As hCG supports the corpus luteum, administration of hCG is used in certain circumstances to enhance the production of progesterone. Several vaccines against human chorionic gonadotropin (hCG) for the prevention of pregnancy are currently in clinical trials.

Sources: en.wikipedia.org

Background from the literature

=== Primary ion source === Three types of ion source are used for SSIMS: electron-impact ionization, surface ionization, or liquid-metal ion sources. In the electron-impact ion source, electrons from a heated filament (cathode) are accelerated towards an anode by a voltage difference where they ionize supply-gas atoms on impact. This source usually operates with noble gases. Typically, the energy is variable from 0.1–5 keV, allowing spot sizes from ~50 μm to several millimeters. Surface ionization sources use Cs+ as the primary beam sources for TOF SIMS. Evaporation of caesium from a heated tungsten surface occurs both as atoms and ions. These ions are then accelerated away from the emitting surface. Since no collisions are involved, the ion beam is very pure, and since evaporation is by thermal means, the energy spread is very small, ~2kT (0.2 eV). The low energy spread and high intrinsic brightness of the ion sources offers the possibility of obtaining small spot sizes. Liquid-metal ion sources draw a liquid metal (usually gallium or bismuth) from a heated reservoir over a tip (radius ≈5 μm) of a needle. An electrostatic field is produced at the tip by an extraction electrode biased negatively in front of the tip. Opposing electrostatic and surface-tension forces acting on the liquid film produce a conical shape with a high-radius-of-curvature cusp (≈2 μm) protruding from the tip. From this cusp field, ion emission occurs, by means of the process of field evaporation.

{\displaystyle {\begin{aligned}{\frac {dS}{dt}}&=\mu N-\mu S-\beta {\frac {I}{N}}S,\quad S(nT^{+})=(1-p)S(nT^{-}),&&n=0,1,2,\ldots \\[8pt]{\frac {dV}{dt}}&=-\mu V,\quad V(nT^{+})=V(nT^{-})+pS(nT^{-}),&&n=0,1,2,\ldots \end{aligned}}}

These independent courts found their existence threatened by warlords, necessitating cooperation which resulted in their unification by 2000. The Islamic Courts Union (ICU) was a broad-based organization comprising various courts with diverse goals, from national political ambitions to local dispute resolution and propagation of Islam. Due to Islam's central role in Somali society, the initiative gained significant popularity and acceptance, along with substantial financial support from the Somali business community, as it originated from the grassroots level, built legitimacy through religious solidarity, addressed local security concerns, and demonstrated a commitment to restoring public order.

Headquarters Großdeutschland Reconnaissance Battalion Großdeutschland Panzer Regiment Großdeutschland Grenadier Regiment Großdeutschland Fusilier Regiment Großdeutschland Engineer Battalion Großdeutschland Artillery Regiment Großdeutschland Tank Destroyer Battalion Großdeutschland Army Anti-Aircraft Battalion Großdeutschland Assault Gun Battalion Großdeutschland Signal Battalion Großdeutschland Divisional Supply Group

== Side effects == There had been concern that lorcaserin could cause cardiac valvulopathy based upon the reports of subjects taking the drug in Phase 2 trials. However, a 2016 Phase 3 clinical trial found no statistically significant differences in valvulopathy rates compared to control, being 2.4% for the drug subjects and 2.0% for controls, and concluded that the drug was safe for the target population although more long-term data was needed. FDA required a post-marketing cardiovascular safety trial as a condition of lorcaserin's approval (a requirement for all weight management drugs since the withdrawal of sibutramine in 2010 due to cardiovascular harm). The CAMELLIA-TIMI 61 trial was conducted for this purpose, and it showed no difference in rates of major adverse cardiovascular events ("MACE+", a composite of "cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, heart failure, or any coronary revascularization") between lorcaserin and placebo. However secondary analysis of CAMELLIA-TIMI 61 by FDA showed a likely higher cancer risk in those taking lorcaserin. The trial was conducted in approximately 12,000 participants over five years and more patients taking lorcaserin were diagnosed with cancer compared to patients taking placebo. CAMELLIA-TIMI 61 was powered to detect differences in MACE, but was not adequately powered to detect differences in cancer rates over the five-year study period.

Sources: en.wikipedia.org

Further detail

S-Arrestin is a protein found in mice that binds to rhodopsin to stop its activity, preventing further signaling. S-arrestin binds to G protein-coupled receptors (GPCRs), like rhodopsin, following receptor activation and phosphorylation by G protein-coupled receptor kinases (GRKs). Rhodopsin is found in rod cells of the retina, essential for vision. It detects light and initiates a signaling cascade called phototransduction. However, excessive activation can be harmful, so it must be carefully regulated. The phosphorylation of the receptor's intracellular loops and C-terminal tail creates a high-affinity binding site for S-arrestin. S-arrestin then sterically hinders further G protein coupling, effectively desensitizing the receptor and directing it towards alternative signaling pathways or internalization via clathrin-mediated endocytosis.

== Development == The mod was developed by Adrian Finol in 2000. Finol created a unique mod that focused on intense, fast paced game-play that set it apart from other total conversion mods. Finol's goal was to create an online first person shooter that was more 'team based' than Counter-Strike, with bonuses for acting with team mates. Several versions were created under Finol's lead, each one adding new features and tweaking the game-play. In late 2001, Finol handed the FLF torch to Dave Dynerman so that he could start a new career with Valve Corporation. Several key contributors of the original FLF team now work for Valve. Under the lead of Dynerman, FLF went through several upgrades, resulting in even more versions. Dynerman went on to join Raven Software early in 2003 and Tony Sergi took over as the lead coder. Sergi created many versions for FLF, although not all became public. As the release of Half-Life 2 approached Sergi, along with the development team, faced a difficult decision. A great deal of time and work from all aspects had gone into the most recent unreleased versions of FLF (1.9 and Defiance), but the mod would have a hard time competing with other mods that were moving to the Half-Life 2 Source engine. Faced with a declining player base and only a handful of members left, the development team with real lifetime constraints for some, put further FLF work on hold.

Promising results of therapeutic candidates are reported: phase I trialed ultrasound BBB-opening device against brain cancer (1 May), phase I trialed personalized mRNA vaccine against pancreatic cancer recurrence (10 May), a novel antibiotic (Streptothricin F) against ABR bacteria (9 May), an e-skin for prosthetic sensing (18 May), two-dose JYNNEOS vaccine against mpox appears ~86% (19 May) or ~66% (18 May) effective, and a xenografted mice-tested pan-KRAS-inhibitor against cancer (31 May).

5-Hydroxytryptophan (5-HTP), used medically as oxitriptan, is a naturally occurring amino acid and chemical precursor as well as a metabolic intermediate in the biosynthesis of the neurotransmitter serotonin. 5-HTP can be manufactured and used as a drug and supplement with the INNTooltip International Nonproprietary Name oxitriptan. Brand names include Cincofarm, Levothym, Levotonine, Oxyfan, Telesol, Tript-OH, and Triptum. As a drug, it is used in the treatment of depression and for certain other indications.

== Uses == Patulin was originally used as an antibiotic against Gram-positive and Gram-negative bacteria, but after several toxicity reports, it is no longer used for that purpose. Isolated by Nancy Atkinson in 1943, it was specifically trialed to be used against the common cold. Patulin is used as a potassium-uptake inhibitor in laboratory applications. Kashif Jilani and co-workers reported that patulin stimulates suicidal erythrocyte death under physiological concentrations.

Sources: en.wikipedia.org

Frequently asked questions

What is epitalon derived from?

It is based on epithalamin, a peptide-rich preparation obtained from pineal gland tissue and studied in the former Soviet Union. Researchers later identified the tetrapeptide AEDG as a constituent fragment of that material. Modern supplies are produced by chemical synthesis rather than tissue extraction.

Is epitalon identical to epithalamin?

No. Epithalamin is a heterogeneous extract containing many peptides, while epitalon is a single synthesised tetrapeptide. Publications sometimes treat findings from the two as equivalent, which is a common source of confusion. Their compositions differ and they are not interchangeable in analytical terms.

Why are human studies so limited?

Most published work uses cell cultures or rodents because those models are faster and less costly to run. The few human trials that have been reported are small, and several lack control groups or blinding. This restricts what can reasonably be concluded about effects in people.

What is epitalon made of?

It is a four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine. The chain is unmodified and contains only standard proteinogenic residues, which makes it straightforward to produce by solid-phase synthesis and to characterise by standard peptide methods.

Network